Product Information
VANACOF LIQUID is a brand product labeled by GM Pharmaceuticals, INC, priced at $0.1051 per ML under NDC 58809099901. Its NADAC has been published 527 times since Nov 28, 2013.
VANACOF LIQUID
Chlophedianol Hydrochloride, Dexchlorpheniramine Maleate, and Pseudoephedrine HydrochlorideStrength
12.5; 1; 30 mg/5mL; mg/5mL; mg/5mL
Manufacturer
GM Pharmaceuticals, INCNDC
58809099901
Classification
Brand
Dosage Form
LIQUID
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
CHLOPHEDIANOL HYDROCHLORIDE; DEXCHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
4/22/2008
Pharmacological Classes
Price Statistics
The NADAC for VANACOF LIQUID has been published 527 times since Nov 28, 2013, and over the history we have for it it has risen 2.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1051 per ML |
|---|---|
| All-time high | $0.1061 (May 13, 2020) |
| All-time low | $0.0968 (Jun 20, 2018) |
| 52-week high | $0.1051 |
| 52-week low | $0.0993 |
| Median price | $0.0982 |
| Average price | $0.0990 |
| Largest weekly change | +9.6% (Feb 19, 2020) |
| Weeks tracked | 527 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Chlophedianol Hydrochloride, Dexchlorpheniramine Maleate, and Pseudoephedrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
GM Pharmaceuticals, INC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chlophedianol Hydrochloride, Dexchlorpheniramine Maleate, and Pseudoephedrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VANACOF LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for VANACOF LIQUID, manufactured by GM Pharmaceuticals, INC, is $0.1051 per ML (NDC 58809099901), effective Sep 30, 2026.
How has the price of VANACOF LIQUID changed over time?
Over the history we have for it, the NADAC for VANACOF LIQUID has risen 2.7%. It has been tracked across 527 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VANACOF LIQUID?
Since Nov 28, 2013, the NADAC for VANACOF LIQUID has ranged from a low of $0.0968 (Jun 20, 2018) to a high of $0.1061 (May 13, 2020), with a median of $0.0982 per ML.
Are there cheaper alternatives to VANACOF LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of VANACOF LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VANACOF LIQUID?
VANACOF LIQUID (NDC 58809099901) is labeled by GM Pharmaceuticals, INC, and CMS classifies it as a brand product.